After being rejected twice by the Botox maker, the Canadian company has taken its $53bn takeover offer direct to Allergan’s shareholders
Source: Companies
Author
Harry Joiner
“… a dominant recruiter in the client-side multichannel ecommerce space …” — SearchEngineWatch.com